公开(公告)号：US20250034141A1

公开(公告)日：2025-01-30

申请号：US18908457

申请日：2024-10-07

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Takaharu HIRAYAMA ,  Yoshiteru ITO ,  Noriyuki NII ,  Youichi KAWAKITA ,  Shinichi IMAMURA

IPC: C07D471/04 ,  C07D487/04

Abstract: Provided is a compound that can have an effect of inhibiting MALT1 and is expected as useful as a prophylactic or therapeutic drug for cancer, etc. A compound represented by formula (I) [wherein each symbol is as defined in the description], a salt thereof, or a cocrystal, a hydrate or a solvate of the same.

公开(公告)号：US20190106437A1

公开(公告)日：2019-04-11

申请号：US16094030

申请日：2017-04-27

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Youichi KAWAKITA ,  Takuto KOJIMA ,  Noriyuki NII ,  Yoshiteru ITO ,  Nobuki SAKAUCHI ,  Hiroshi BANNO ,  Xin LIU ,  Koji ONO ,  Keisuke IMAMURA ,  Shinichi IMAMURA

IPC: C07D519/00 ,  A61P35/00

Abstract: Provided is a compound represented by the following formula, or a salt thereof: [wherein each symbol is as defined herein.].

公开(公告)号：US20210115067A1

公开(公告)日：2021-04-22

申请号：US17130297

申请日：2020-12-22

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Youichi KAWAKITA ,  Takuto KOJIMA ,  Noriyuki NII ,  Yoshiteru ITO ,  Nobuki SAKAUCHI ,  Hiroshi BANNO ,  Xin LIU ,  Koji ONO ,  Keisuke IMAMURA ,  Shinichi IMAMURA

IPC: C07D519/00 ,  A61K31/444 ,  A61K31/53 ,  A61K31/5025 ,  A61K31/519 ,  A61K31/4985 ,  A61P35/00

Abstract: Provided is a compound represented by the following formula, or a salt thereof: [wherein each symbol is as defined herein.].